P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion

Masazumi Arai, Yoshihiro Masui, Pascal Goldschmidt-Clermont, Anthony DiPaula, Cynthia Siu, Takeshi Kondo, Lewis C. Becker

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVES: This study was designed to determine whether antibody neutralization of the adhesion protein P-selectin would prevent neutrophil activation and reduce myocardial reperfusion injury. BACKGROUND: Although inhibition of P-selectin markedly reduces short-term myocardial injury after ischemia and reperfusion, it is unknown whether it can provide meaningful long-term protection and preserve left ventricular function. METHODS: Closed- chest dogs underwent 90 min left anterior descending coronary artery occlusion and 48 h reperfusion, and were randomized to 1) a treatment group (n = 11) receiving 1 mg/kg of the blocking anti-P-selectin antibody PB1.3, or 2) a control group receiving 1 mg/kg PNB1.6 (nonblocking antibody against P- selectin, n = 7) or an equivalent volume of saline (n = 2) 10 min before reperfusion. Infarct size was assessed postmortem by triphenyl tetrazolium chloride staining. Contrast left ventriculography was used to measure left ventricular function. Activation of circulating polymorphonuclear neutrophils (PMNs) was assessed by an increase in surface CD18 expression. RESULTS: Neutrophil activation was observed at 30 min after reperfusion in the control group, but was abolished in the treatment group. Infarct size was reduced about 25% in the treatment group after controlling for variations in ischemic blood flow (p = 0.003, by analysis of covariance). However, this protective effect was not associated with preservation of blood flow to the ischemic- reperfused myocardium, nor with any improvement in global or regional left ventricular function. CONCLUSIONS: The anti-P-selectin antibody PB1.3 prevented early PMN activation, but had only a modest long-term infarct- limiting effect over 48 h reperfusion. Adhesion molecules other than P- selectin may mediate delayed PMN activation and accumulation in reperfused myocardium.

Original languageEnglish
Pages (from-to)280-288
Number of pages9
JournalJournal of the American College of Cardiology
Volume34
Issue number1
DOIs
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

Neutrophil Activation
P-Selectin
Reperfusion
Ischemia
Dogs
Wounds and Injuries
Left Ventricular Function
Antibodies
Myocardium
Blood Preservation
Myocardial Reperfusion Injury
Control Groups
Coronary Occlusion
Reperfusion Injury
Chlorides
Coronary Vessels
Neutrophils
Thorax
Therapeutics
Staining and Labeling

ASJC Scopus subject areas

  • Nursing(all)

Cite this

P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion. / Arai, Masazumi; Masui, Yoshihiro; Goldschmidt-Clermont, Pascal; DiPaula, Anthony; Siu, Cynthia; Kondo, Takeshi; Becker, Lewis C.

In: Journal of the American College of Cardiology, Vol. 34, No. 1, 01.07.1999, p. 280-288.

Research output: Contribution to journalArticle

Arai, Masazumi ; Masui, Yoshihiro ; Goldschmidt-Clermont, Pascal ; DiPaula, Anthony ; Siu, Cynthia ; Kondo, Takeshi ; Becker, Lewis C. / P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion. In: Journal of the American College of Cardiology. 1999 ; Vol. 34, No. 1. pp. 280-288.
@article{2e39df17a2eb4be3a37ff10a3b95d38b,
title = "P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion",
abstract = "OBJECTIVES: This study was designed to determine whether antibody neutralization of the adhesion protein P-selectin would prevent neutrophil activation and reduce myocardial reperfusion injury. BACKGROUND: Although inhibition of P-selectin markedly reduces short-term myocardial injury after ischemia and reperfusion, it is unknown whether it can provide meaningful long-term protection and preserve left ventricular function. METHODS: Closed- chest dogs underwent 90 min left anterior descending coronary artery occlusion and 48 h reperfusion, and were randomized to 1) a treatment group (n = 11) receiving 1 mg/kg of the blocking anti-P-selectin antibody PB1.3, or 2) a control group receiving 1 mg/kg PNB1.6 (nonblocking antibody against P- selectin, n = 7) or an equivalent volume of saline (n = 2) 10 min before reperfusion. Infarct size was assessed postmortem by triphenyl tetrazolium chloride staining. Contrast left ventriculography was used to measure left ventricular function. Activation of circulating polymorphonuclear neutrophils (PMNs) was assessed by an increase in surface CD18 expression. RESULTS: Neutrophil activation was observed at 30 min after reperfusion in the control group, but was abolished in the treatment group. Infarct size was reduced about 25{\%} in the treatment group after controlling for variations in ischemic blood flow (p = 0.003, by analysis of covariance). However, this protective effect was not associated with preservation of blood flow to the ischemic- reperfused myocardium, nor with any improvement in global or regional left ventricular function. CONCLUSIONS: The anti-P-selectin antibody PB1.3 prevented early PMN activation, but had only a modest long-term infarct- limiting effect over 48 h reperfusion. Adhesion molecules other than P- selectin may mediate delayed PMN activation and accumulation in reperfused myocardium.",
author = "Masazumi Arai and Yoshihiro Masui and Pascal Goldschmidt-Clermont and Anthony DiPaula and Cynthia Siu and Takeshi Kondo and Becker, {Lewis C.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1016/S0735-1097(99)00160-6",
language = "English",
volume = "34",
pages = "280--288",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion

AU - Arai, Masazumi

AU - Masui, Yoshihiro

AU - Goldschmidt-Clermont, Pascal

AU - DiPaula, Anthony

AU - Siu, Cynthia

AU - Kondo, Takeshi

AU - Becker, Lewis C.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - OBJECTIVES: This study was designed to determine whether antibody neutralization of the adhesion protein P-selectin would prevent neutrophil activation and reduce myocardial reperfusion injury. BACKGROUND: Although inhibition of P-selectin markedly reduces short-term myocardial injury after ischemia and reperfusion, it is unknown whether it can provide meaningful long-term protection and preserve left ventricular function. METHODS: Closed- chest dogs underwent 90 min left anterior descending coronary artery occlusion and 48 h reperfusion, and were randomized to 1) a treatment group (n = 11) receiving 1 mg/kg of the blocking anti-P-selectin antibody PB1.3, or 2) a control group receiving 1 mg/kg PNB1.6 (nonblocking antibody against P- selectin, n = 7) or an equivalent volume of saline (n = 2) 10 min before reperfusion. Infarct size was assessed postmortem by triphenyl tetrazolium chloride staining. Contrast left ventriculography was used to measure left ventricular function. Activation of circulating polymorphonuclear neutrophils (PMNs) was assessed by an increase in surface CD18 expression. RESULTS: Neutrophil activation was observed at 30 min after reperfusion in the control group, but was abolished in the treatment group. Infarct size was reduced about 25% in the treatment group after controlling for variations in ischemic blood flow (p = 0.003, by analysis of covariance). However, this protective effect was not associated with preservation of blood flow to the ischemic- reperfused myocardium, nor with any improvement in global or regional left ventricular function. CONCLUSIONS: The anti-P-selectin antibody PB1.3 prevented early PMN activation, but had only a modest long-term infarct- limiting effect over 48 h reperfusion. Adhesion molecules other than P- selectin may mediate delayed PMN activation and accumulation in reperfused myocardium.

AB - OBJECTIVES: This study was designed to determine whether antibody neutralization of the adhesion protein P-selectin would prevent neutrophil activation and reduce myocardial reperfusion injury. BACKGROUND: Although inhibition of P-selectin markedly reduces short-term myocardial injury after ischemia and reperfusion, it is unknown whether it can provide meaningful long-term protection and preserve left ventricular function. METHODS: Closed- chest dogs underwent 90 min left anterior descending coronary artery occlusion and 48 h reperfusion, and were randomized to 1) a treatment group (n = 11) receiving 1 mg/kg of the blocking anti-P-selectin antibody PB1.3, or 2) a control group receiving 1 mg/kg PNB1.6 (nonblocking antibody against P- selectin, n = 7) or an equivalent volume of saline (n = 2) 10 min before reperfusion. Infarct size was assessed postmortem by triphenyl tetrazolium chloride staining. Contrast left ventriculography was used to measure left ventricular function. Activation of circulating polymorphonuclear neutrophils (PMNs) was assessed by an increase in surface CD18 expression. RESULTS: Neutrophil activation was observed at 30 min after reperfusion in the control group, but was abolished in the treatment group. Infarct size was reduced about 25% in the treatment group after controlling for variations in ischemic blood flow (p = 0.003, by analysis of covariance). However, this protective effect was not associated with preservation of blood flow to the ischemic- reperfused myocardium, nor with any improvement in global or regional left ventricular function. CONCLUSIONS: The anti-P-selectin antibody PB1.3 prevented early PMN activation, but had only a modest long-term infarct- limiting effect over 48 h reperfusion. Adhesion molecules other than P- selectin may mediate delayed PMN activation and accumulation in reperfused myocardium.

UR - http://www.scopus.com/inward/record.url?scp=0033165671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033165671&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(99)00160-6

DO - 10.1016/S0735-1097(99)00160-6

M3 - Article

VL - 34

SP - 280

EP - 288

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 1

ER -